Comparison between gluten-free regime and regime with gluten in symptoms of patients with irritable bowel syndrome (IBS)
- PMID: 31198738
- PMCID: PMC6559066
- DOI: 10.4103/jfmpc.jfmpc_464_18
Comparison between gluten-free regime and regime with gluten in symptoms of patients with irritable bowel syndrome (IBS)
Abstract
Background and objective: Irritable bowel syndrome (IBS) is the most common gastrointestinal disorder and accounts for most of the referrals of patients to gastroenterologists. Given the high prevalence of this syndrome and its significant effect on the reduced quality of life of patients, the present study aimed to investigate the effect of using gluten-containing or gluten-free diet on symptoms of patients with irritable bowel syndrome.
Materials and methods: In this trial, 140 patients with irritable bowel syndrome who referred to Imam Khomeini Hospital (2006) were randomly divided into two groups based on Rome III criteria. Seventy patients received a gluten-free diet and rest patent received a regular diet as control group for 12 weeks. In order to compare the quantitative characteristics, independent samples T-test was used, while Mann-Whitney and Z-tests were used to compare the qualitative characteristics.
Findings: There was no significant difference between the control group (9.8 ± 37 years) and the group with gluten-free diet (0.2 ± 37 years) in terms of mean age. The effect of gluten-free diet on intestinal gas, fecal consistency, urgent need for expulsion, and insufficient defecation were higher than in control group. Although abdominal pain and reduced frequency of bowel movements were higher in the control group than gluten-free diet group (P < 0.05). The positive response to general improvement in the gluten-free group and in the control group was 67% and 52%, respectively.
Conclusion: According to present results, providing gluten-free diet could be improved patient treatment's symptoms. Also, it seemed that the duration of treatment can lead to better therapeutic outcomes.
Keywords: Gastrointestinal disorders; gluten; irritable bowel syndrome (IBS).
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.Nutrients. 2015 Jun 5;7(6):4542-54. doi: 10.3390/nu7064542. Nutrients. 2015. PMID: 26056920 Free PMC article. Clinical Trial.
-
Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG.Clin Gastroenterol Hepatol. 2021 Nov;19(11):2343-2352.e8. doi: 10.1016/j.cgh.2020.08.040. Epub 2020 Aug 19. Clin Gastroenterol Hepatol. 2021. PMID: 32827724
-
Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial.Intest Res. 2016 Oct;14(4):343-350. doi: 10.5217/ir.2016.14.4.343. Epub 2016 Oct 17. Intest Res. 2016. PMID: 27799885 Free PMC article.
-
Efficacy of the gluten free diet in the management of functional gastrointestinal disorders: a systematic review on behalf of the Italian Society of Paediatrics.Ital J Pediatr. 2019 Jan 11;45(1):9. doi: 10.1186/s13052-019-0606-1. Ital J Pediatr. 2019. PMID: 30635010 Free PMC article.
-
A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.Am J Gastroenterol. 2018 Sep;113(9):1290-1300. doi: 10.1038/s41395-018-0195-4. Epub 2018 Jul 26. Am J Gastroenterol. 2018. PMID: 30046155
Cited by
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
Gluten restriction in irritable bowel syndrome, yes or no?: a GRADE-assessed systematic review and meta-analysis.Front Nutr. 2023 Nov 1;10:1273629. doi: 10.3389/fnut.2023.1273629. eCollection 2023. Front Nutr. 2023. PMID: 38024368 Free PMC article.
References
-
- Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology. 1991;100:998–1005. - PubMed
-
- Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–11. - PubMed
-
- Thompson W, Irvine E, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002;47:225–35. - PubMed
-
- Hoseini-Asl M, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol. 2003;22:215–6. - PubMed